There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
Latest posts by Hippocratic Post (see all)
- Long hospital stays reach worst levels this winter - 6th February 2026
- 1960s Men’s Gym - 6th February 2026
- NHS trials low impact sleep apnoea device - 6th February 2026
